King Pharmaceuticals KG Business Segments
| FY'25 | ||
|---|---|---|
| Net premiums earned by Business | ||
| AmTrust Reinsurance | $4.91M— | |
| Legacy Reinsurance | $12.67M— | |
| Net premiums written by Business | ||
| AmTrust Reinsurance | -$1.24M— | |
| Legacy Reinsurance | $6.21M— | |
| Concentration risk, percentage by Business | ||
| AmTrust Reinsurance | 38.7%— | |
| Summit Reinsurance Segment | 21.2%— | |
| Total Diversified Reinsurance adverse PPD by Product | ||
| GLS | $262K— | |
| International | $824K— | |
| Net premiums earned by Geography | ||
| North America | -$80K— | |
| Other (predominantly Europe) | $12.75M— | |
| Gross premiums written by Geography | ||
| North America | -$195K— | |
| Other (predominantly Europe) | $6.29M— | |
| Net premiums written by Geography | ||
| North America | -$80K— | |
| Other (predominantly Europe) | $6.29M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does King Pharmaceuticals break its business down?
- King Pharmaceuticals (KG) reports net premiums earned by business across 4 parts — AmTrust Legacy Segment, AmTrust Reinsurance, Diversified Legacy Segment and Legacy Reinsurance. Each is extracted from the segment footnotes and tracked over time.
- Where does King Pharmaceuticals's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in King Pharmaceuticals's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
